Search alternatives:
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greater decrease » greater increase (Expand Search), greater increases (Expand Search), rate decreased (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
821
-
822
Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis
Published 2013“…<div><p>Background and Aim</p><p>Liver cirrhosis is associated with decreased hepatic cytochrome P4503A (CYP3A) activity but the pathogenesis of this phenomenon is not well elucidated. …”
-
823
-
824
-
825
Change of potential ecosystem services (decrease (↘) and increase (↗) greater than 10%) between practices in each category of grassland, for the drastic and local scenario (column...
Published 2014“…<p>Change of potential ecosystem services (decrease (↘) and increase (↗) greater than 10%) between practices in each category of grassland, for the drastic and local scenario (column “D”) and the intermittent and international scenario (column “I”) (data from <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0107572#pone.0107572-Lamarque4" target="_blank">[61]</a>).…”
-
826
-
827
-
828
Emission spectra of S100A1 fluorescence titrations exhibiting decreasing fluorescence intensities with increasing concentration of S100B at the μM level.
Published 2018“…<p>Emission spectra of S100A1 fluorescence titrations exhibiting decreasing fluorescence intensities with increasing concentration of S100B at the μM level.…”
-
829
Supplementary Material for: Blood Outgrowth Endothelial Cells Reduce Hypoxia-Mediated Fibroblast to Myofibroblast Conversion by Decreasing Proangiogenic Cytokines
Published 2017“…This is associated with a decrease in several proangiogenic genes including vascular endothelial growth factor A, platelet-derived growth factor, fibroblast growth factor and matrix metalloproteinase 2 in fibroblasts in contact with BOEC when compared to fibroblasts alone. …”
-
830
-
831
A major isoform of mitochondrial <i>trans</i>-2-enoyl-CoA reductase is dispensable for wax ester production in <i>Euglena gracilis</i> under anaerobic conditions
Published 2019“…We herein generated EgTER1-knockdown <i>Euglena</i> cells, in which total crotonyl-CoA reductase activity was decreased to 10% of control value. …”
-
832
-
833
-
834
-
835
-
836
-
837
Table_2_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.DOCX
Published 2020“…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
-
838
Image_1_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.TIF
Published 2020“…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
-
839
Table_1_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.DOCX
Published 2020“…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”
-
840
Image_4_The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.TIFF
Published 2020“…Cerebrospinal fluid Aβ42/Aβ40 ratios were increased in mild AD and decreased in moderate AD patients treated with nilvadipine, compared to their respective controls. …”